Gulla Krishna Mohan, Sachdev Anil, Gupta Dhiren, Gupta Neeraj, Anand Kanav, Pruthi P K
Division of Pediatric Emergency and Critical Care, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India.
Division of Pediatric Nephrology, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India.
Indian J Crit Care Med. 2015 Oct;19(10):613-7. doi: 10.4103/0972-5229.167044.
Scanty literature is available regarding continuous renal replacement therapy (CRRT) utility in severe sepsis with multiorgan dysfunction syndrome (MODS) from developing countries. Author unit's experience in pediatric CRRT is described and outcome of early initiation of CRRT with sepsis and MODS is assessed.
Children aged <16 years with sepsis and MODS who required CRRT from September 2010 to February 2015 were analyzed on demographic factors, timing of initiation of CRRT, mode of CRRT, effect of CRRT onhemodynamics, oxygenation parameters, and outcome.
Twenty-seven children required CRRT (male - 16). The median age was 11 years (range 1.1-16). Twenty-one had severe sepsis with MODS. Eighteen patients were given CRRT within 48 h of admission to Intensive Care Unit (ICU). Statistically significant improvement in the P/F ratio, decrement in plateau pressure and vasoactive-inotropic score were noted in survivor group compared to nonsurvivor group (P = 0.022, 0.00, and 0.03, respectively). There was no statistically significant difference in duration of ICU stay, fluid overload, CRRT duration, PRISM score at 12 and 24 h, percentage of decrease in inotrope score, plateau pressure, and percentage of increase in P/F ratio in relation to timing of CRRT initiation. However, the survival rate was 61.1% (11/18) who received CRRT within 48 h of ICU admission compared to 33.3% (3/9) who received after 48 h (P = 0.0001).
Our study emphasizes the CRRT role in improving the oxygenation status and hemodynamics. Survival benefit may be expected in those children who receive CRRT early in the course of sepsis. However, multicenter RCTs are required to prove mortality benefit.
关于发展中国家重症脓毒症合并多器官功能障碍综合征(MODS)患者应用持续肾脏替代治疗(CRRT)的文献较少。本文描述了作者所在单位在儿科CRRT方面的经验,并评估了脓毒症和MODS患者早期开始CRRT的疗效。
分析2010年9月至2015年2月期间年龄<16岁、因脓毒症和MODS需要进行CRRT的儿童的人口统计学因素、CRRT开始时间、CRRT模式、CRRT对血流动力学、氧合参数的影响及治疗结果。
27例儿童需要进行CRRT(男16例)。中位年龄为11岁(范围1.1 - 16岁)。21例为重症脓毒症合并MODS。18例患者在入住重症监护病房(ICU)48小时内接受了CRRT。与非存活组相比,存活组的P/F比值有统计学意义的改善,平台压降低,血管活性药物 - 正性肌力药物评分降低(P分别为0.022、0.00和0.03)。在ICU住院时间、液体超负荷、CRRT持续时间、12小时和24小时的PRISM评分、血管活性药物评分降低百分比、平台压以及P/F比值升高百分比方面,与CRRT开始时间无关,差异无统计学意义。然而,ICU入院48小时内接受CRRT的患者存活率为61.1%(11/18),而48小时后接受CRRT的患者存活率为33.3%(3/9)(P = 0.0001)。
我们的研究强调了CRRT在改善氧合状态和血流动力学方面的作用。脓毒症病程早期接受CRRT的儿童可能预期有生存获益。然而,需要多中心随机对照试验来证实对死亡率的益处。